1. Hansman, D, Bullen, MM. A resistant pneumococcus. Lancet 1967; 2: 264–265.
2. Klugman, KP. Pneumococcal resistance to antibiotics. Clinical Microbiology Reviews 1990; 3: 171–196.
3. Appelbaum, PC. Antimicrobial resistance in Streptococcus pneumoniae: an overview. Clinical Infectious Diseases 1992; 15: 77–83.
4. Phongsamart, W, et al. Serotype distribution and antimicrobial susceptibility of S. pneumoniae causing invasive disease in Thai children younger than 5 years old, 2000–2005. Vaccine 2007; 25: 1275–1280.
5. Heffernan, HM, et al. Invasive pneumococcal disease in New Zealand 1998–2005: capsular serotypes and antimicrobial resistance. Epidemiology and Infection 2008; 136: 352–359.
6. Bruce, MG, et al. International circumpolar surveillance system for invasive pneumococcal disease, 1999–2005. Emerging Infectious Diseases 2008; 14: 25–33.
7. Pebody, RG, et al. Pneumococcal disease surveillance in Europe. Eurosurveillance 2006; 11: 171–178.
8. Centers for Disease Control and Prevention. Progress in introduction of pneumococcal conjugate vaccine – worldwide, 2000–2008. Morbidity Mortality Weekly Report 2008; 57: 1148–1151.
9. Ubukata, K, et al. Identification of penicillin and other beta-lactam resistance in Streptococcus pneumoniae by polymerase chain reaction. Journal of Infection and Chemotherapy 1997; 3: 190–197.
10. Ubukata, K. Problems associated with high prevalence of multidrug-resistant bacteria in patients with community-acquired infections. Journal of Infection and Chemotherapy 2003; 9: 285–291.
11. Ubukata, K, et al. Combinational detection of autolysin and penicillin-binding protein 2B genes of Streptococcus pneumoniae by PCR. Journal of Clinical Microbiology 1996; 34: 592–596.
12. Chiba, N, et al. Antibiotic susceptibility according to genotype of penicillin-binding protein and macrolide resistance genes, and serotype of Streptococcus pneumoniae isolates from community-acquired pneumonia in children. Journal of Antimicrobial Chemotherapy 2005; 56: 756–760.
13. Reinert, RR. Pneumococcal conjugate vaccines – a European perspective. International Journal of Medical Microbiology 2004; 294: 77–94.
14. Advisory Committee on Immunization Practices. Preventing pneumococcal disease among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recommendations and Reports 2000; 49: 1–35.
15. Centers for Disease Control and Prevention. Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease – United States, 1998–2003. Morbidity Mortality Weekly Report 2005; 54: 893–897.
16. Lexau, CA, et al. Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine. Journal of the American Medical Association 2005; 294: 2043–2051.
17. Poehling, KA, et al. Invasive pneumococcal disease among infants before and after introduction of pneumococcal conjugate vaccine. Journal of the American Medical Association 2006; 295: 1668–1674.
18. Black, S, et al. Surveillance for invasive pneumococcal disease during 2000–2005 in a population of children who received 7-valent pneumococcal conjugate vaccine. Pediatric Infectious Diseases Journal 2007; 26: 771–777.
19. Pelton, SI, et al. Emergence of 19A as virulent and multidrug resistant Pneumococcus in Massachusetts following universal immunization of infants with pneumococcal conjugate vaccine. Pediatric Infectious Diseases Journal 2007; 26: 468–472.
20. Farrell, DJ, Klugman, KP, Pichichero, M. Increased antimicrobial resistance among nonvaccine serotypes of Streptococcus pneumoniae in the pediatric population after the introduction of 7-valent pneumococcal vaccine in the United States. Pediatric Infectious Diseases Journal 2007; 26: 123–128.
21. Centers for Disease Control and Prevention. Invasive pneumococcal disease in children 5 years after conjugate vaccine introduction – eight states, 1998–2005. Morbidity Mortality Weekly Report 2008; 57: 144–148.
22. Ubukata, K, et al. Antibiotic susceptibility in relation to penicillin-binding protein genes and serotype distribution of Streptococcus pneumoniae strains responsible for meningitis in Japan, 1999 to 2002. Antimicrobial Agents and Chemotherapy 2004; 48: 1488–1494.
23. Ubukata, K, et al. Incidence of penicillin-resistant Streptococcus pneumoniae in Japan, 1993–1995. Journal of Infection and Chemotherapy 1996; 1: 177–184.
24. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: 18th informational supplement. Wayne, PA, USA: CLSI, 2008; CLSI document M100-S18.
25. Garcia, P, et al. Nucleotide sequence and expression of the pneumococcal autolysin gene from its own promoter in Escherichia coli. Gene 1986; 43: 265–272.
26. Nagai, K, et al. Evaluation of PCR primers to screen for Streptococcus pneumoniae isolates and beta-lactam resistance, and to detect common macrolide resistance determinants. Journal of Antimicrobial Chemotherapy 2001; 48: 915–918.
27. Center, KJ. Prevenar vaccination: review of the global data, 2006. Vaccine 2007; 25: 3085–3089.
28. Scott, D, et al. Phase 1 trial of 13-valent pneumococcal conjugate vaccine in Japanese adults. Pediatr Int 2008; 50: 295–299.
29. Yamanaka, N, Hotomi, M, Billal, DS. Clinical bacteriology and immunology in acute otitis media in children. Journal of Infection and Chemotherapy 2008; 14: 180–187.
30. Ubukata, K, Iwata, S, Sunakawa, K. In vitro activities of new ketolide, telithromycin, and eight other macrolide antibiotics against Streptococcus pneumoniae having mefA and ermB genes that mediate macrolide resistance. Journal of Infection and Chemotherapy 2003; 9: 221–226.
31. Tunkel, AR, et al. Practice guidelines for the management of bacterial meningitis. Clinical Infectious Diseases 2004; 39: 1267–1284.
32. Hasegawa, K, et al. High prevalence of type b beta-lactamase-non-producing ampicillin-resistant Haemophilus influenzae in meningitis: the situation in Japan where Hib vaccine has not been introduced. Journal of Antimicrobial Chemotherapy 2006; 57: 1077–1082.